

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.53679454 |
| 2 | viral transcription (GO:0019083) | 5.82425757 |
| 3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.76748230 |
| 4 | DNA deamination (GO:0045006) | 5.73468188 |
| 5 | translational termination (GO:0006415) | 5.53779828 |
| 6 | respiratory electron transport chain (GO:0022904) | 5.37350724 |
| 7 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.35328380 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.31687826 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 5.31270554 |
| 10 | electron transport chain (GO:0022900) | 5.28175343 |
| 11 | cotranslational protein targeting to membrane (GO:0006613) | 5.25646697 |
| 12 | protein targeting to ER (GO:0045047) | 5.18496737 |
| 13 | protein neddylation (GO:0045116) | 5.00461485 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.95926227 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.93384242 |
| 16 | translational elongation (GO:0006414) | 4.75711064 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.59442048 |
| 18 | viral life cycle (GO:0019058) | 4.41587490 |
| 19 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.15559125 |
| 20 | platelet dense granule organization (GO:0060155) | 4.11719072 |
| 21 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.11250880 |
| 22 | cellular protein complex disassembly (GO:0043624) | 4.09552289 |
| 23 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.08983044 |
| 24 | response to interferon-beta (GO:0035456) | 4.08963609 |
| 25 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.08632281 |
| 26 | maturation of SSU-rRNA (GO:0030490) | 4.06745252 |
| 27 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.03817853 |
| 28 | negative regulation of ligase activity (GO:0051352) | 4.03817853 |
| 29 | proteasome assembly (GO:0043248) | 3.97681295 |
| 30 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.83850238 |
| 31 | cullin deneddylation (GO:0010388) | 3.83673940 |
| 32 | ATP biosynthetic process (GO:0006754) | 3.72823932 |
| 33 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.71542594 |
| 34 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.71542594 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.71472597 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.71472597 |
| 37 | lymphoid progenitor cell differentiation (GO:0002320) | 3.69608176 |
| 38 | translational initiation (GO:0006413) | 3.69397073 |
| 39 | protein targeting to mitochondrion (GO:0006626) | 3.68973230 |
| 40 | protein-cofactor linkage (GO:0018065) | 3.64423246 |
| 41 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.63592026 |
| 42 | protein deneddylation (GO:0000338) | 3.62997364 |
| 43 | hydrogen ion transmembrane transport (GO:1902600) | 3.62503556 |
| 44 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.62376722 |
| 45 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.62376722 |
| 46 | rRNA modification (GO:0000154) | 3.62254940 |
| 47 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.60807068 |
| 48 | respiratory chain complex IV assembly (GO:0008535) | 3.60450216 |
| 49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.59740817 |
| 50 | signal peptide processing (GO:0006465) | 3.56115745 |
| 51 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.54842719 |
| 52 | establishment of protein localization to mitochondrion (GO:0072655) | 3.53109338 |
| 53 | protein complex biogenesis (GO:0070271) | 3.52966005 |
| 54 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.52937986 |
| 55 | DNA damage response, detection of DNA damage (GO:0042769) | 3.51622236 |
| 56 | NADH dehydrogenase complex assembly (GO:0010257) | 3.51586232 |
| 57 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.51586232 |
| 58 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.51586232 |
| 59 | positive regulation of ligase activity (GO:0051351) | 3.49494712 |
| 60 | spliceosomal snRNP assembly (GO:0000387) | 3.49424671 |
| 61 | protein localization to mitochondrion (GO:0070585) | 3.48176369 |
| 62 | protein complex disassembly (GO:0043241) | 3.45267324 |
| 63 | inner mitochondrial membrane organization (GO:0007007) | 3.43973617 |
| 64 | daunorubicin metabolic process (GO:0044597) | 3.43339994 |
| 65 | polyketide metabolic process (GO:0030638) | 3.43339994 |
| 66 | doxorubicin metabolic process (GO:0044598) | 3.43339994 |
| 67 | protein targeting to membrane (GO:0006612) | 3.42816446 |
| 68 | sequestering of actin monomers (GO:0042989) | 3.39991417 |
| 69 | translation (GO:0006412) | 3.33960090 |
| 70 | metallo-sulfur cluster assembly (GO:0031163) | 3.32705575 |
| 71 | iron-sulfur cluster assembly (GO:0016226) | 3.32705575 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.31339829 |
| 73 | proton transport (GO:0015992) | 3.28321522 |
| 74 | ribosomal large subunit biogenesis (GO:0042273) | 3.27705535 |
| 75 | macromolecular complex disassembly (GO:0032984) | 3.26256601 |
| 76 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.26065389 |
| 77 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25079114 |
| 78 | hydrogen transport (GO:0006818) | 3.21702536 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21158855 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.19083386 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.17575145 |
| 82 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.16080533 |
| 83 | cellular response to interferon-beta (GO:0035458) | 3.15582641 |
| 84 | regulation of mitochondrial translation (GO:0070129) | 3.14473783 |
| 85 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.13290220 |
| 86 | cytochrome complex assembly (GO:0017004) | 3.12663787 |
| 87 | DNA double-strand break processing (GO:0000729) | 3.12475827 |
| 88 | 7-methylguanosine mRNA capping (GO:0006370) | 3.12290875 |
| 89 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12243335 |
| 90 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.11997743 |
| 91 | defense response to protozoan (GO:0042832) | 3.09705369 |
| 92 | regulation of ligase activity (GO:0051340) | 3.06311391 |
| 93 | chromatin remodeling at centromere (GO:0031055) | 3.05964255 |
| 94 | intracellular protein transmembrane import (GO:0044743) | 3.04890619 |
| 95 | 7-methylguanosine RNA capping (GO:0009452) | 3.04077742 |
| 96 | RNA capping (GO:0036260) | 3.04077742 |
| 97 | mannosylation (GO:0097502) | 3.03761830 |
| 98 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.02894273 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.01728094 |
| 100 | CENP-A containing nucleosome assembly (GO:0034080) | 3.01603654 |
| 101 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.01564877 |
| 102 | mRNA catabolic process (GO:0006402) | 3.00536114 |
| 103 | regulation of cellular amine metabolic process (GO:0033238) | 3.00348209 |
| 104 | mitochondrial transport (GO:0006839) | 2.99395682 |
| 105 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.97383089 |
| 106 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.96711344 |
| 107 | termination of RNA polymerase III transcription (GO:0006386) | 2.96711344 |
| 108 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.94428043 |
| 109 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.93993440 |
| 110 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.93183068 |
| 111 | pseudouridine synthesis (GO:0001522) | 2.92987181 |
| 112 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.91430240 |
| 113 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.91430240 |
| 114 | establishment of integrated proviral latency (GO:0075713) | 2.90058867 |
| 115 | GTP biosynthetic process (GO:0006183) | 2.89965822 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.89626016 |
| 117 | chaperone-mediated protein transport (GO:0072321) | 2.89409391 |
| 118 | cellular component biogenesis (GO:0044085) | 2.89188862 |
| 119 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.88888053 |
| 120 | response to protozoan (GO:0001562) | 2.86636195 |
| 121 | definitive hemopoiesis (GO:0060216) | 2.86560546 |
| 122 | mast cell activation (GO:0045576) | 2.83661623 |
| 123 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83336221 |
| 124 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.83089370 |
| 125 | maturation of 5.8S rRNA (GO:0000460) | 2.82738232 |
| 126 | deoxyribonucleotide catabolic process (GO:0009264) | 2.81368906 |
| 127 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.76410012 |
| 128 | peptidyl-histidine modification (GO:0018202) | 2.76179910 |
| 129 | RNA catabolic process (GO:0006401) | 2.74392439 |
| 130 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.71398149 |
| 131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.69525060 |
| 132 | GPI anchor biosynthetic process (GO:0006506) | 2.69358074 |
| 133 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.69245983 |
| 134 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68845354 |
| 135 | deoxyribose phosphate catabolic process (GO:0046386) | 2.67132363 |
| 136 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.66972421 |
| 137 | ATP synthesis coupled proton transport (GO:0015986) | 2.66972421 |
| 138 | * deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.65611614 |
| 139 | telomere maintenance via recombination (GO:0000722) | 2.64711761 |
| 140 | oxidative phosphorylation (GO:0006119) | 2.64561751 |
| 141 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.64258428 |
| 142 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.64258428 |
| 143 | positive regulation of B cell differentiation (GO:0045579) | 2.62238797 |
| 144 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.61376822 |
| 145 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.61376822 |
| 146 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.61376822 |
| 147 | establishment of viral latency (GO:0019043) | 2.60546413 |
| 148 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.60440986 |
| 149 | isotype switching (GO:0045190) | 2.60440986 |
| 150 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.60440986 |
| 151 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.58649500 |
| 152 | mature B cell differentiation involved in immune response (GO:0002313) | 2.57686552 |
| 153 | DNA strand elongation (GO:0022616) | 2.55076977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.04101138 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.76065515 |
| 3 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.48383705 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.34424334 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.27165548 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.19651579 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.16540209 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.15162612 |
| 9 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.07028441 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.04794813 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03977135 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.01973626 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.01602894 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.91699471 |
| 15 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.81011541 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.77012271 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76571005 |
| 18 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62702623 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.61704589 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58523933 |
| 21 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.53860791 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51335941 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47195646 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41508719 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.40951259 |
| 26 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.39673365 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.37964693 |
| 28 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.35270100 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.24988914 |
| 30 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.20219690 |
| 31 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.15524390 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15446076 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.13532870 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12046535 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.10082628 |
| 36 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.00996676 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00501160 |
| 38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99036449 |
| 39 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.98808664 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96088640 |
| 41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93970536 |
| 42 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.93524964 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.89513062 |
| 44 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84219180 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.82436200 |
| 46 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.79177620 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76743527 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74412068 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74399670 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73095322 |
| 51 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.71110762 |
| 52 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.63636481 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60347601 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56342743 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.54929897 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.53173849 |
| 57 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.50199926 |
| 58 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.48054611 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47359747 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47260171 |
| 61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45197988 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44776175 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.43232751 |
| 64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42393410 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39337111 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37872158 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34153982 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33540526 |
| 69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31825710 |
| 70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.30662027 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28921495 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26987726 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25881289 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25412683 |
| 75 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25149793 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24924953 |
| 77 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24859386 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.24819750 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24391825 |
| 80 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22509122 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21751593 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20006498 |
| 83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16253289 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15600817 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14382161 |
| 86 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.13992838 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13348495 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13316354 |
| 89 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.12620997 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09949213 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08502625 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08010452 |
| 93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.07323699 |
| 94 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07285889 |
| 95 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06319396 |
| 96 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05967978 |
| 97 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05938756 |
| 98 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05729038 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05042648 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.04595314 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04025303 |
| 102 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03641041 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03249854 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03041640 |
| 105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02976878 |
| 106 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02542813 |
| 107 | MAF_26560356_Chip-Seq_TH1_Human | 1.01795632 |
| 108 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99268867 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.98739738 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97280382 |
| 111 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96838194 |
| 112 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96090974 |
| 113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96075637 |
| 114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96068193 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95596901 |
| 116 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94148942 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93362727 |
| 118 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.93355797 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93310721 |
| 120 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92882273 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92596226 |
| 122 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90959323 |
| 123 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90593012 |
| 124 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90593012 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 0.90140862 |
| 126 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.89450496 |
| 127 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89410023 |
| 128 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89099622 |
| 129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87678403 |
| 130 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87386829 |
| 131 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86995850 |
| 132 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84904467 |
| 133 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84732431 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83647906 |
| 135 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.82397003 |
| 136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.80252318 |
| 137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.80252318 |
| 138 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76489361 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76410708 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76121297 |
| 141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74149330 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73729101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.63350339 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.39250403 |
| 3 | MP0005671_abnormal_response_to | 3.19098156 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.17328373 |
| 5 | MP0000685_abnormal_immune_system | 3.07705257 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.90644262 |
| 7 | MP0003724_increased_susceptibility_to | 2.84773599 |
| 8 | MP0009785_altered_susceptibility_to | 2.74732899 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.72723320 |
| 10 | MP0002102_abnormal_ear_morphology | 2.66096040 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.53791553 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.43512261 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.39060693 |
| 14 | MP0003718_maternal_effect | 2.37872472 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.37440271 |
| 16 | MP0005025_abnormal_response_to | 2.24628717 |
| 17 | MP0001800_abnormal_humoral_immune | 2.20044224 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.17358221 |
| 19 | MP0004147_increased_porphyrin_level | 2.16503105 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.13963810 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.12653644 |
| 22 | MP0002723_abnormal_immune_serum | 2.10472796 |
| 23 | MP0001819_abnormal_immune_cell | 2.08054763 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.05886753 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 2.05487304 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.03366732 |
| 27 | MP0002398_abnormal_bone_marrow | 2.02859570 |
| 28 | MP0003880_abnormal_central_pattern | 1.98564245 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.97083697 |
| 30 | MP0001790_abnormal_immune_system | 1.92129757 |
| 31 | MP0005387_immune_system_phenotype | 1.92129757 |
| 32 | MP0002095_abnormal_skin_pigmentation | 1.90953181 |
| 33 | MP0001984_abnormal_olfaction | 1.88608836 |
| 34 | MP0002419_abnormal_innate_immunity | 1.84127042 |
| 35 | MP0000716_abnormal_immune_system | 1.82056387 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.81319637 |
| 37 | MP0001853_heart_inflammation | 1.80865122 |
| 38 | MP0008058_abnormal_DNA_repair | 1.78820409 |
| 39 | MP0003866_abnormal_defecation | 1.78603844 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.77827613 |
| 41 | MP0001873_stomach_inflammation | 1.77753410 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.75953654 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.75851890 |
| 44 | MP0003436_decreased_susceptibility_to | 1.74380926 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.68431500 |
| 46 | MP0002132_abnormal_respiratory_system | 1.67163847 |
| 47 | MP0001188_hyperpigmentation | 1.65567041 |
| 48 | MP0002736_abnormal_nociception_after | 1.64534405 |
| 49 | MP0002722_abnormal_immune_system | 1.64216201 |
| 50 | MP0002429_abnormal_blood_cell | 1.64117228 |
| 51 | MP0003011_delayed_dark_adaptation | 1.61910808 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.59138195 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.57924760 |
| 54 | MP0001529_abnormal_vocalization | 1.53091174 |
| 55 | MP0005409_darkened_coat_color | 1.52869766 |
| 56 | MP0002163_abnormal_gland_morphology | 1.52776913 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.51647082 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.51452703 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.50254199 |
| 60 | MP0000490_abnormal_crypts_of | 1.47167996 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.46624050 |
| 62 | MP0008995_early_reproductive_senescence | 1.46518912 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.45476858 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.45045699 |
| 65 | MP0003122_maternal_imprinting | 1.44518322 |
| 66 | MP0002006_tumorigenesis | 1.43375841 |
| 67 | MP0003195_calcinosis | 1.42365531 |
| 68 | MP0005394_taste/olfaction_phenotype | 1.42360155 |
| 69 | MP0005499_abnormal_olfactory_system | 1.42360155 |
| 70 | MP0005253_abnormal_eye_physiology | 1.42249296 |
| 71 | MP0003186_abnormal_redox_activity | 1.41554473 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.41402798 |
| 73 | MP0003121_genomic_imprinting | 1.40265193 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39192941 |
| 75 | MP0002822_catalepsy | 1.36782455 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.36441685 |
| 77 | MP0003111_abnormal_nucleus_morphology | 1.35951141 |
| 78 | MP0001293_anophthalmia | 1.35927374 |
| 79 | MP0002405_respiratory_system_inflammati | 1.35755808 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.35509870 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.35509870 |
| 82 | MP0008932_abnormal_embryonic_tissue | 1.33827105 |
| 83 | MP0005646_abnormal_pituitary_gland | 1.32433377 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.31436196 |
| 85 | MP0002933_joint_inflammation | 1.27461709 |
| 86 | MP0004133_heterotaxia | 1.27043591 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 1.26926629 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.25697264 |
| 89 | MP0000703_abnormal_thymus_morphology | 1.25198006 |
| 90 | MP0008872_abnormal_physiological_respon | 1.21603128 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 1.20740674 |
| 92 | MP0009697_abnormal_copulation | 1.19680767 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.18249662 |
| 94 | MP0009046_muscle_twitch | 1.16760891 |
| 95 | MP0003315_abnormal_perineum_morphology | 1.16549191 |
| 96 | MP0010094_abnormal_chromosome_stability | 1.15179120 |
| 97 | MP0001905_abnormal_dopamine_level | 1.14613946 |
| 98 | MP0002210_abnormal_sex_determination | 1.14452261 |
| 99 | MP0008469_abnormal_protein_level | 1.12211068 |
| 100 | MP0003786_premature_aging | 1.10381361 |
| 101 | MP0000681_abnormal_thyroid_gland | 1.09518148 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08951730 |
| 103 | MP0004381_abnormal_hair_follicle | 1.08066997 |
| 104 | MP0000678_abnormal_parathyroid_gland | 1.06212014 |
| 105 | MP0003787_abnormal_imprinting | 1.05568686 |
| 106 | MP0010386_abnormal_urinary_bladder | 1.05503876 |
| 107 | MP0002090_abnormal_vision | 1.05487797 |
| 108 | MP0006082_CNS_inflammation | 1.03400533 |
| 109 | MP0001929_abnormal_gametogenesis | 1.02098105 |
| 110 | MP0000653_abnormal_sex_gland | 0.98182754 |
| 111 | MP0003077_abnormal_cell_cycle | 0.96789530 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.96246220 |
| 113 | MP0001145_abnormal_male_reproductive | 0.93854524 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.93378214 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.93014003 |
| 116 | MP0009745_abnormal_behavioral_response | 0.91892997 |
| 117 | MP0002938_white_spotting | 0.91481950 |
| 118 | MP0002272_abnormal_nervous_system | 0.90485222 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.89708374 |
| 120 | MP0005670_abnormal_white_adipose | 0.88444608 |
| 121 | MP0002160_abnormal_reproductive_system | 0.86896073 |
| 122 | MP0000516_abnormal_urinary_system | 0.86146844 |
| 123 | MP0005367_renal/urinary_system_phenotyp | 0.86146844 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.86067977 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.85775268 |
| 126 | MP0005410_abnormal_fertilization | 0.85555868 |
| 127 | MP0003698_abnormal_male_reproductive | 0.85392732 |
| 128 | MP0000358_abnormal_cell_content/ | 0.85256071 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.85117399 |
| 130 | MP0000647_abnormal_sebaceous_gland | 0.84695560 |
| 131 | MP0006072_abnormal_retinal_apoptosis | 0.84187601 |
| 132 | MP0003136_yellow_coat_color | 0.83071452 |
| 133 | MP0005636_abnormal_mineral_homeostasis | 0.82185456 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.79711054 |
| 135 | MP0002233_abnormal_nose_morphology | 0.79691664 |
| 136 | MP0005389_reproductive_system_phenotype | 0.78181942 |
| 137 | MP0003938_abnormal_ear_development | 0.77525983 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.77150196 |
| 139 | MP0003937_abnormal_limbs/digits/tail_de | 0.75949471 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.74525032 |
| 141 | MP0004957_abnormal_blastocyst_morpholog | 0.74516589 |
| 142 | MP0001919_abnormal_reproductive_system | 0.74154570 |
| 143 | MP0003119_abnormal_digestive_system | 0.73396611 |
| 144 | MP0001851_eye_inflammation | 0.73298871 |
| 145 | MP0005332_abnormal_amino_acid | 0.72814265 |
| 146 | MP0000313_abnormal_cell_death | 0.72220780 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.71592939 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.71013049 |
| 149 | MP0002752_abnormal_somatic_nervous | 0.70961257 |
| 150 | MP0000343_altered_response_to | 0.70841461 |
| 151 | MP0003806_abnormal_nucleotide_metabolis | 0.70790589 |
| 152 | MP0003137_abnormal_impulse_conducting | 0.70381141 |
| 153 | MP0006054_spinal_hemorrhage | 0.69697369 |
| 154 | MP0002735_abnormal_chemical_nociception | 0.69313580 |
| 155 | MP0001324_abnormal_eye_pigmentation | 0.68455653 |
| 156 | MP0000049_abnormal_middle_ear | 0.68265602 |
| 157 | MP0009764_decreased_sensitivity_to | 0.68206864 |
| 158 | MP0005451_abnormal_body_composition | 0.68038292 |
| 159 | MP0001119_abnormal_female_reproductive | 0.67721322 |
| 160 | MP0001186_pigmentation_phenotype | 0.67645358 |
| 161 | MP0002909_abnormal_adrenal_gland | 0.67330601 |
| 162 | MP0001764_abnormal_homeostasis | 0.66893667 |
| 163 | MP0005391_vision/eye_phenotype | 0.66591474 |
| 164 | MP0002693_abnormal_pancreas_physiology | 0.64871898 |
| 165 | MP0004510_myositis | 0.63748413 |
| 166 | MP0002075_abnormal_coat/hair_pigmentati | 0.63066670 |
| 167 | MP0002009_preneoplasia | 0.63026659 |
| 168 | MP0004142_abnormal_muscle_tone | 0.62412146 |
| 169 | MP0004947_skin_inflammation | 0.61610729 |
| 170 | MP0005379_endocrine/exocrine_gland_phen | 0.60106294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.25219833 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.14126715 |
| 3 | Aplastic anemia (HP:0001915) | 4.45161843 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 4.24407938 |
| 5 | IgM deficiency (HP:0002850) | 3.80904607 |
| 6 | Reticulocytopenia (HP:0001896) | 3.76922653 |
| 7 | Cerebral edema (HP:0002181) | 3.72324536 |
| 8 | * Hepatocellular necrosis (HP:0001404) | 3.70074927 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.55590608 |
| 10 | * Hepatic necrosis (HP:0002605) | 3.47958569 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.47869608 |
| 12 | Chronic otitis media (HP:0000389) | 3.43654157 |
| 13 | Thrombocytosis (HP:0001894) | 3.41424996 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.36730535 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.36730535 |
| 16 | Abnormal protein glycosylation (HP:0012346) | 3.36730535 |
| 17 | Abnormal glycosylation (HP:0012345) | 3.36730535 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 3.36139216 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.32857493 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28415262 |
| 21 | * Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.11541235 |
| 22 | * Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.11541235 |
| 23 | Increased intramyocellular lipid droplets (HP:0012240) | 3.03521998 |
| 24 | Increased CSF lactate (HP:0002490) | 2.94854326 |
| 25 | Macrocytic anemia (HP:0001972) | 2.93396948 |
| 26 | Petechiae (HP:0000967) | 2.89138011 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.86652477 |
| 28 | Optic disc pallor (HP:0000543) | 2.84961811 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 2.84206352 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.83245617 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.82975129 |
| 32 | Pallor (HP:0000980) | 2.81517992 |
| 33 | Increased muscle lipid content (HP:0009058) | 2.80849419 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.80323990 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.79214532 |
| 36 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.77330251 |
| 37 | Abnormality of B cell number (HP:0010975) | 2.74603216 |
| 38 | B lymphocytopenia (HP:0010976) | 2.74603216 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.73040536 |
| 40 | Abnormality of renal resorption (HP:0011038) | 2.69487308 |
| 41 | Renal Fanconi syndrome (HP:0001994) | 2.68817547 |
| 42 | Lipid accumulation in hepatocytes (HP:0006561) | 2.68197026 |
| 43 | Myositis (HP:0100614) | 2.64506910 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 2.63432294 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 2.63432294 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.61984089 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.61539336 |
| 48 | Abnormality of the columella (HP:0009929) | 2.58701264 |
| 49 | Type 2 muscle fiber atrophy (HP:0003554) | 2.58326490 |
| 50 | Acute encephalopathy (HP:0006846) | 2.57619510 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.57220807 |
| 52 | Increased serum lactate (HP:0002151) | 2.55029583 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.50316394 |
| 54 | Exertional dyspnea (HP:0002875) | 2.50203536 |
| 55 | Congenital, generalized hypertrichosis (HP:0004540) | 2.48318283 |
| 56 | Recurrent bacterial skin infections (HP:0005406) | 2.46053762 |
| 57 | Lethargy (HP:0001254) | 2.45860996 |
| 58 | Glycosuria (HP:0003076) | 2.44769601 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.44769601 |
| 60 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.40185337 |
| 61 | Abnormality of the labia minora (HP:0012880) | 2.39357648 |
| 62 | Progressive macrocephaly (HP:0004481) | 2.39035381 |
| 63 | IgG deficiency (HP:0004315) | 2.37980616 |
| 64 | Degeneration of anterior horn cells (HP:0002398) | 2.37385227 |
| 65 | Abnormality of the anterior horn cell (HP:0006802) | 2.37385227 |
| 66 | * Lactic acidosis (HP:0003128) | 2.36830074 |
| 67 | Hyperglycinemia (HP:0002154) | 2.34208716 |
| 68 | Muscle fiber atrophy (HP:0100295) | 2.34134842 |
| 69 | Severe visual impairment (HP:0001141) | 2.34003446 |
| 70 | Colon cancer (HP:0003003) | 2.33915956 |
| 71 | Patchy hypopigmentation of hair (HP:0011365) | 2.30835862 |
| 72 | Pancytopenia (HP:0001876) | 2.29521726 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.28077235 |
| 74 | Neutropenia (HP:0001875) | 2.25506641 |
| 75 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.23813262 |
| 76 | Exercise intolerance (HP:0003546) | 2.23588984 |
| 77 | Eczematoid dermatitis (HP:0000976) | 2.22038040 |
| 78 | Microcytic anemia (HP:0001935) | 2.21549745 |
| 79 | Nephronophthisis (HP:0000090) | 2.20804565 |
| 80 | Pancreatic cysts (HP:0001737) | 2.20441514 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.19484732 |
| 82 | Lymphoma (HP:0002665) | 2.15764153 |
| 83 | Asplenia (HP:0001746) | 2.14696408 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.13648337 |
| 85 | CNS demyelination (HP:0007305) | 2.12833100 |
| 86 | Oral leukoplakia (HP:0002745) | 2.12656362 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.12539573 |
| 88 | Congenital primary aphakia (HP:0007707) | 2.10921571 |
| 89 | Broad face (HP:0000283) | 2.10674105 |
| 90 | True hermaphroditism (HP:0010459) | 2.10594341 |
| 91 | Pancreatic fibrosis (HP:0100732) | 2.09382812 |
| 92 | Hypoproteinemia (HP:0003075) | 2.08334311 |
| 93 | Gait imbalance (HP:0002141) | 2.07890615 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.06153263 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.03802225 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 2.02716734 |
| 97 | Sclerocornea (HP:0000647) | 2.00832545 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00708518 |
| 99 | Epistaxis (HP:0000421) | 1.99834379 |
| 100 | X-linked dominant inheritance (HP:0001423) | 1.96735706 |
| 101 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.96454962 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95689331 |
| 103 | Emotional lability (HP:0000712) | 1.94905173 |
| 104 | Respiratory failure (HP:0002878) | 1.94858135 |
| 105 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94065803 |
| 106 | White forelock (HP:0002211) | 1.92987724 |
| 107 | Septo-optic dysplasia (HP:0100842) | 1.92093235 |
| 108 | Poor head control (HP:0002421) | 1.91192441 |
| 109 | Abnormality of T cells (HP:0002843) | 1.90734749 |
| 110 | Recurrent skin infections (HP:0001581) | 1.89859819 |
| 111 | Lymphopenia (HP:0001888) | 1.89605229 |
| 112 | Cerebral hypomyelination (HP:0006808) | 1.89380131 |
| 113 | Meningitis (HP:0001287) | 1.88675238 |
| 114 | Erythema (HP:0010783) | 1.86697637 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.85449633 |
| 116 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.85423739 |
| 117 | Gonadotropin excess (HP:0000837) | 1.85000961 |
| 118 | Respiratory difficulties (HP:0002880) | 1.84564284 |
| 119 | Recurrent viral infections (HP:0004429) | 1.84045841 |
| 120 | Premature graying of hair (HP:0002216) | 1.78721732 |
| 121 | Purpura (HP:0000979) | 1.78607115 |
| 122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77457223 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.76708578 |
| 124 | Meckel diverticulum (HP:0002245) | 1.76482096 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.76141999 |
| 126 | Methylmalonic aciduria (HP:0012120) | 1.75924784 |
| 127 | Leukodystrophy (HP:0002415) | 1.75670880 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 1.75532352 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75532352 |
| 130 | Abnormality of serum amino acid levels (HP:0003112) | 1.73289985 |
| 131 | Genital tract atresia (HP:0001827) | 1.73146745 |
| 132 | Vaginal atresia (HP:0000148) | 1.71877107 |
| 133 | Abnormality of the ileum (HP:0001549) | 1.69280699 |
| 134 | Poor suck (HP:0002033) | 1.69145712 |
| 135 | Hypoplasia of the pons (HP:0012110) | 1.67977214 |
| 136 | Abnormality of the pons (HP:0007361) | 1.67953483 |
| 137 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.66742547 |
| 138 | Abnormality of the renal medulla (HP:0100957) | 1.65214397 |
| 139 | Abnormality of methionine metabolism (HP:0010901) | 1.64652800 |
| 140 | Congenital stationary night blindness (HP:0007642) | 1.63540800 |
| 141 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.63413862 |
| 142 | Abnormality of vitamin B metabolism (HP:0004340) | 1.62728419 |
| 143 | Blindness (HP:0000618) | 1.61709954 |
| 144 | Hypoglycemic coma (HP:0001325) | 1.61577388 |
| 145 | Delayed CNS myelination (HP:0002188) | 1.59662971 |
| 146 | Median cleft lip (HP:0000161) | 1.57922379 |
| 147 | Male pseudohermaphroditism (HP:0000037) | 1.57626325 |
| 148 | Hyperglycinuria (HP:0003108) | 1.57200442 |
| 149 | Renal cortical cysts (HP:0000803) | 1.56963653 |
| 150 | Increased serum pyruvate (HP:0003542) | 1.56920679 |
| 151 | Pendular nystagmus (HP:0012043) | 1.54466772 |
| 152 | Short tibia (HP:0005736) | 1.53873119 |
| 153 | Myokymia (HP:0002411) | 1.53309601 |
| 154 | Anencephaly (HP:0002323) | 1.52703517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.48483574 |
| 2 | NME2 | 3.58159770 |
| 3 | CDK19 | 3.34860888 |
| 4 | KIT | 3.18587142 |
| 5 | TNIK | 2.98928309 |
| 6 | STK16 | 2.92838996 |
| 7 | MAP4K1 | 2.83758806 |
| 8 | FLT3 | 2.78187334 |
| 9 | MAP3K12 | 2.71872991 |
| 10 | ZAK | 2.59555164 |
| 11 | MAP4K2 | 2.40744505 |
| 12 | TXK | 2.39296541 |
| 13 | NME1 | 2.34812692 |
| 14 | WNK3 | 2.33738730 |
| 15 | MUSK | 2.31933451 |
| 16 | TEC | 2.22251120 |
| 17 | TESK2 | 2.12994652 |
| 18 | NUAK1 | 2.12976227 |
| 19 | BTK | 2.06061072 |
| 20 | TRIM28 | 1.99668994 |
| 21 | TGFBR1 | 1.92206428 |
| 22 | CDC7 | 1.91973889 |
| 23 | VRK1 | 1.88210120 |
| 24 | IRAK4 | 1.79384224 |
| 25 | WEE1 | 1.78434429 |
| 26 | PBK | 1.76318164 |
| 27 | TGFBR2 | 1.72424523 |
| 28 | NEK1 | 1.68007160 |
| 29 | BCKDK | 1.66373559 |
| 30 | EIF2AK3 | 1.65603443 |
| 31 | KDR | 1.60301478 |
| 32 | PLK3 | 1.56441068 |
| 33 | MYLK | 1.53756343 |
| 34 | ZAP70 | 1.51012073 |
| 35 | JAK3 | 1.48421990 |
| 36 | CSF1R | 1.47640843 |
| 37 | BCR | 1.46025130 |
| 38 | MAPKAPK5 | 1.43261045 |
| 39 | SYK | 1.40669384 |
| 40 | CDK8 | 1.34969004 |
| 41 | IKBKE | 1.31869188 |
| 42 | PIM2 | 1.31308894 |
| 43 | BUB1 | 1.27736694 |
| 44 | TSSK6 | 1.27341940 |
| 45 | CSNK1G1 | 1.23579616 |
| 46 | CSNK1G2 | 1.19852719 |
| 47 | TAF1 | 1.19309427 |
| 48 | GRK1 | 1.18840525 |
| 49 | TBK1 | 1.18384700 |
| 50 | IKBKB | 1.17278436 |
| 51 | ADRBK2 | 1.15598235 |
| 52 | TIE1 | 1.14892350 |
| 53 | BRSK2 | 1.13838203 |
| 54 | MAP2K7 | 1.12062665 |
| 55 | TTK | 1.10120096 |
| 56 | PASK | 1.09261196 |
| 57 | MAP3K4 | 1.08026126 |
| 58 | RPS6KB2 | 1.05832399 |
| 59 | BMPR1B | 1.05547849 |
| 60 | TAOK3 | 1.05220789 |
| 61 | EIF2AK1 | 1.04996061 |
| 62 | BLK | 1.03322910 |
| 63 | NLK | 1.02458889 |
| 64 | MAP2K3 | 1.01799295 |
| 65 | ARAF | 1.01088965 |
| 66 | MKNK1 | 1.00112251 |
| 67 | INSRR | 0.99512783 |
| 68 | CSNK1A1L | 0.96896118 |
| 69 | LCK | 0.95948426 |
| 70 | ILK | 0.95629073 |
| 71 | PLK1 | 0.95611265 |
| 72 | LYN | 0.93690250 |
| 73 | ACVR1B | 0.90995624 |
| 74 | TYK2 | 0.88087494 |
| 75 | CAMK1 | 0.87704221 |
| 76 | DYRK3 | 0.86351596 |
| 77 | MAPK13 | 0.86102318 |
| 78 | IRAK3 | 0.85832695 |
| 79 | LIMK1 | 0.84477067 |
| 80 | CASK | 0.84307432 |
| 81 | CAMKK2 | 0.83793769 |
| 82 | DAPK1 | 0.83677735 |
| 83 | FRK | 0.83628191 |
| 84 | MAPK15 | 0.82522988 |
| 85 | PLK2 | 0.81504939 |
| 86 | MKNK2 | 0.81101973 |
| 87 | MAP2K6 | 0.79533641 |
| 88 | SRPK1 | 0.77238311 |
| 89 | LRRK2 | 0.75772459 |
| 90 | MINK1 | 0.73099987 |
| 91 | WNK4 | 0.72357859 |
| 92 | MOS | 0.70244407 |
| 93 | TLK1 | 0.70097889 |
| 94 | AURKB | 0.69893750 |
| 95 | ERBB3 | 0.67928651 |
| 96 | PDK2 | 0.67546575 |
| 97 | STK10 | 0.67272236 |
| 98 | SIK3 | 0.67122932 |
| 99 | PRKCG | 0.66198778 |
| 100 | GRK7 | 0.66175040 |
| 101 | CSNK2A2 | 0.66174745 |
| 102 | PRKG2 | 0.65611877 |
| 103 | MAP3K13 | 0.65549392 |
| 104 | MATK | 0.64599077 |
| 105 | EIF2AK2 | 0.64536217 |
| 106 | BMPR2 | 0.62884619 |
| 107 | PLK4 | 0.60251559 |
| 108 | MAP3K6 | 0.59883255 |
| 109 | HIPK2 | 0.57567596 |
| 110 | ITK | 0.56320096 |
| 111 | TESK1 | 0.54532096 |
| 112 | AURKA | 0.53741631 |
| 113 | ABL2 | 0.53021143 |
| 114 | MST4 | 0.52789511 |
| 115 | YES1 | 0.52452584 |
| 116 | CDK7 | 0.51831045 |
| 117 | MAPK4 | 0.51668162 |
| 118 | CHEK2 | 0.51375097 |
| 119 | PRKCE | 0.51159092 |
| 120 | MAPKAPK3 | 0.49252547 |
| 121 | CLK1 | 0.49116351 |
| 122 | MAP3K7 | 0.48822033 |
| 123 | TNK2 | 0.48202005 |
| 124 | MAP3K11 | 0.48164448 |
| 125 | CCNB1 | 0.48134627 |
| 126 | PHKG1 | 0.47616518 |
| 127 | PHKG2 | 0.47616518 |
| 128 | RPS6KA5 | 0.44371542 |
| 129 | MAP3K14 | 0.44075696 |
| 130 | ADRBK1 | 0.43273456 |
| 131 | ATM | 0.42264059 |
| 132 | RPS6KA6 | 0.41214966 |
| 133 | CSNK1A1 | 0.40817756 |
| 134 | FES | 0.40600425 |
| 135 | DAPK3 | 0.40265065 |
| 136 | PRKCI | 0.39733577 |
| 137 | PINK1 | 0.37883110 |
| 138 | DYRK2 | 0.37120337 |
| 139 | ATR | 0.36674434 |
| 140 | IRAK1 | 0.36068565 |
| 141 | CSNK1G3 | 0.36023434 |
| 142 | BRAF | 0.35753147 |
| 143 | PAK3 | 0.35499757 |
| 144 | CSNK1E | 0.35451759 |
| 145 | MAP2K2 | 0.34501924 |
| 146 | NEK6 | 0.33731596 |
| 147 | GRK5 | 0.32836785 |
| 148 | STK39 | 0.32519760 |
| 149 | PRKCQ | 0.32193261 |
| 150 | CAMK2A | 0.31938155 |
| 151 | CSNK2A1 | 0.31760725 |
| 152 | BRSK1 | 0.31691802 |
| 153 | PRKCD | 0.31396612 |
| 154 | OXSR1 | 0.30699418 |
| 155 | PIM1 | 0.30243313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.30376507 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.63696585 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.17551309 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.14029540 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.89263796 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.71832614 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.39625321 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.39053341 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.36945402 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.30182308 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.27540137 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.25391549 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.11642032 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.03550889 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.02082082 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.97314757 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.78182344 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70178778 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66390347 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52503007 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50090310 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.49856319 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45337522 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40865654 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40798364 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.34547268 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32854924 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28497672 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.27653347 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25935779 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24995455 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23529562 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20263325 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17199046 |
| 35 | * Purine metabolism_Homo sapiens_hsa00230 | 1.16923717 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.11149119 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10973203 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09827752 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.09493515 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09301392 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08891866 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05091316 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01664617 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.01542853 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99594372 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99412854 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97346264 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97132137 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96900466 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96646227 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95454629 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94887123 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94814526 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94438427 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94123958 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91172026 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88776901 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85188499 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84176467 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83513629 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81151869 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80630232 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79726163 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77791344 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.77260195 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75214288 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71483074 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.69967630 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.66364521 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.66145051 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65562295 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64432277 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.63434231 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62481860 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62356852 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62233950 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61013766 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.60581126 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60012551 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59518658 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58955879 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58871642 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57902566 |
| 84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57042174 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55245381 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54401457 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54153571 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.53955080 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53702247 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53471860 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52788381 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52244073 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51406504 |
| 94 | Legionellosis_Homo sapiens_hsa05134 | 0.49903725 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47843095 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46815247 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46031308 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45615404 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44569461 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44067173 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43960559 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42673963 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42131424 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42089486 |
| 105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41791128 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41738290 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41732402 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40187661 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40174733 |
| 110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39970943 |
| 111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39116912 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38670462 |
| 113 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37983307 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37435723 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37207766 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35871309 |
| 117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34938549 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34691228 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32565562 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.32156635 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31884411 |
| 122 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31642758 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31210548 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.29538171 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28529160 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28020280 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26812251 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.25950926 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25605524 |
| 130 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25006512 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24984007 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24775863 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.23926830 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23898754 |
| 135 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22859313 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22519640 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22411550 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20973640 |
| 139 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.20889131 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.20803780 |
| 141 | ABC transporters_Homo sapiens_hsa02010 | 0.20428852 |
| 142 | Taste transduction_Homo sapiens_hsa04742 | 0.19480055 |

